Table 2.
Association of circFARSA expression with clinicopathological characteristics in 40 patients with NSCLC [n (%)].
| Parameters | circFARSA expression |
P value | |
|---|---|---|---|
| Low (n = 22) | High (n = 18) | ||
| Gender | 0.771 | ||
| Male | 12(30.00) | 10(25.00) | |
| Female | 10(25.00) | 8(20.00) | |
| Age (years) | 0.565 | ||
| ≤60 | 9(22.50) | 9(22.50) | |
| >60 | 13(32.50) | 9(22.50) | |
| Smoking history | 0.842 | ||
| Smokers | 14(35.00) | 12(30.00) | |
| Never smokers | 8(20.00) | 6(15.00) | |
| TNM stage | 0.013 | ||
| I-II | 16(40.00) | 6(15.00) | |
| III-IV | 6(15.00) | 12(30.00) | |
| Tumor size (cm) | 0.014 | ||
| ≤5 | 17(42.50) | 7(17.50) | |
| >5 | 5(12.50) | 11(27.50) | |
| LNM | 0.024 | ||
| Yes | 8(20.00) | 13(32.50) | |
| No | 14(35.00) | 5(12.50) | |
Note: The median of relative circFARSA expression level is 2.22, so the number of high circFARSA expression is 18 (>2.22). TNM: Tumor, node, metastasis; LNM: lymph node metastasis.